-
NUMBER OF INSIDER BUYING
(Last 12 Months)
1 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
0 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$7.60 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$0
CG Oncology, Inc. Common stock Insider Transactions
CG Oncology, Inc. Common stock Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Decheng Capital Global Life Sciences Fund IV, L.P.
10 percent owner |
Buy | 400,000 @ $19.00 | $7.60 M | 400,000 | 01/29/2024 | 01/31/2024 |
CG Oncology, Inc. Common stock Frequently Asked Questions
-
Who is on CG Oncology, Inc. Common stock's Insider Roster?
The list of insiders at CG Oncology, Inc. Common stock includes Decheng Capital Global Life Sciences Fund IV, L.P..
-
How much insider buying is happening at CG Oncology, Inc. Common stock?
Insiders have purchased a total of 400,000 CG Oncology, Inc. Common stock shares in the last 12 months for a total of 7.60 M sold.
-
Which CG Oncology, Inc. Common stock insiders have been buying company stock?
The following insiders have purchased CG Oncology, Inc. Common stock shares in the last 12 months: Decheng Capital Global Life Sciences Fund IV, L.P. ($7.60 M),